Provention Bio, Inc.

Profitability for 1 year: 0%
Dividend yield: 0%
Sector: Healthcare

Provention Bio, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
-20.25 29.98 -167.54% -8.78 +130.53%
P/S 56.73 127.74 -55.59%
P/BV 6 249.13 -97.59%
P/FCF -30.18 -171.72 -82.42%
Ev/Ebitda -5.71 -23.82 -76.05%
Ev/S 55.15 524.37 -89.48%
Ev/FCF -9.34 -276.27 -96.62%
E/P -0.0494 0.0223 -321.33%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-966.67 -358.56 169.59% -2430.8 -60.23%
ROE 133.43 102.4 30.3%
ROA -60.98 -1.94 3039.8%
ROIC -74.56 0.7 -10678.95%
ROS -993.8 -148.28 570.21%
ROCE -105.17 3.78 -2885.16%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.19 1.52 -112.62% -0.19 -0.0097%
Nеt Debt/Ebitda 0.16 1.46 -88.96%
Debt/Ratio 0.1 0.2 -48.99%
Debt/Equity 0.94 1.61 -41.3%
Debt/Net Income -0.21 -1.12 -81.27%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.55 -100% 0 0%
Number of years of dividend growth 0 0.91 -100%
DSI 0 0.22 -100%
Average dividend growth 0 3.92 -100%
Average percentage for 5 years 0 0.51 -100%
Average percentage for payments 0 56.13 -100%
Difference from average difference in sector -0.55

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
821.43 -47.77 -1819.55%
Growth impulse Ebitda in 5 years 181.31 -76.11 -338.22%
Growth impulse Net Income in 5 years 167.77 -71.25 -335.47%
Growth impulse FCF in 5 years 111.08 -63.52 -274.87%
Growth impulse EPS in 5 years 45.19 -37.1 -221.81%
IP Score
4.56/10

Similar companies

ABIOMED

Alexion

Gilead Sciences

Amgen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription